Instructor

The petition was approved based on 43 peer-reviewed articles, 2 book chapters, and 6 patents which garnered 362 citations from researchers in 35 countries. Additionally, the petitioner demonstrated extraordinary ability through a significant record of 70 peer review assignments for professional journals. These metrics satisfied the EB-1A criteria for scholarly articles, original contributions, and judging the work of others.

The petitioner satisfied EB-1A criteria through 23 peer-reviewed scientific articles and 1 patent, which garnered 496 citations from researchers in 35 countries. Additionally, his expertise was recognized through 16 completed peer-review assignments for major international journals. His original contributions to medicinal chemistry and cancer research were validated by independent expert testimony.

The petition was approved based on meeting at least three EB-1A criteria: authorship of scholarly articles, participation as a judge of others' work, and original scientific contributions of major significance. Specific metrics included 34 journal articles in high-impact venues like Cell Chemical Biology, 1,306 citations with an h-index of 17, and over 25 completed manuscript reviews. Evidence of the commercialization of key compounds further demonstrated the petitioner's extraordinary ability.

The approval was based on a significant publication record of 28 journal articles and a citation count exceeding 360, placing the petitioner in the top 1% of his field. Additionally, his 25 peer reviews and original contributions to antimicrobial and antidiabetic agents satisfied the EB-1A criteria.